Kasabach-Merritt Phenomenon
Male
Infant, Newborn
Infant
Kasabach-Merritt Syndrome
Combined Modality Therapy
3. Good health
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
Humans
Female
Retrospective Studies
DOI:
10.1097/mph.0b013e318281558e
Publication Date:
2013-02-06T15:16:45Z
AUTHORS (15)
ABSTRACT
Kasabach-Merritt phenomenon (KMP) is a rare condition and optimal treatments have not yet been established, especially for cases that are unresponsive to first-line therapy. We retrospectively reviewed 11 KMP cases treated over the past 13 years in our institute.With the exception of 1 case, steroids were administered as the first-line therapy. Eight cases required second-line or third-line therapy. The effective salvage therapies include interferon (n=1), radiotherapy (n=1), and chemotherapy (n=5). One case continues to depend upon chemotherapy. Three refractory cases were therapy dependent over 1 year of age, whereas 8 were treated effectively by 6 months of age.Chemotherapy seems to be the most effective therapy for steroid-resistant KMP cases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (4)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....